STOCK

Advertisement
Dec 06 2025FINANCE

FICO: A Closer Look at the Numbers

FICO, a big name in tech, is getting some attention from analysts. One expert, Ashish Sabadra, thinks it's a good time to invest. He gave it a "Buy" rating and predicts the stock could reach $2, 400. Right now, it's trading at $1, 771. 87. But what's the bigger picture? Well, most analysts seem to

reading time less than a minute
Dec 05 2025BUSINESS

Twenty One Capital Set to Hit the Stock Market

Twenty One Capital, Inc. is on the brink of becoming a publicly traded company. This follows the green light from shareholders of Cantor Equity Partners, Inc. (CEP) for a merger between the two firms. The approval came through during an Extraordinary General Meeting held on December 3rd. The merger

reading time less than a minute
Dec 05 2025FINANCE

Revolution Medicines: A Rising Star in Cancer Research

Revolution Medicines (RVMD) has been making waves in the stock market, reaching new heights. The company is valued at $15 billion and is focused on developing treatments for cancers caused by mutations in RAS proteins. This is a big deal because these types of cancers are tough to treat. The stock

reading time less than a minute
Dec 05 2025FINANCE

Cobalt Prices Skyrocket, U. S. Defense Agency Reevaluates Stockpile Plans

The U. S. Defense Logistics Agency (DLA) is taking a step back to rethink its cobalt purchasing strategy. With cobalt prices surging by 50% since August, the agency is now reassessing its plans to stockpile this crucial metal. The DLA's initial tender, which aimed to purchase 7, 480 metric tons of c

reading time less than a minute
Dec 04 2025FINANCE

Trump's Crypto Bet: A Roller Coaster Ride

The Trump family's financial ventures have hit a rough patch lately. Their assets aren't doing as well as the rest of the market. This is especially true for their crypto investments. Eric Trump's American Bitcoin (ABTC) took a big hit. It dropped almost 50% in early trading on Tuesday. By the end o

reading time less than a minute
Dec 04 2025HEALTH

A New Hope in Lung Cancer Treatment

Black Diamond Therapeutics has shared some promising news about their drug, silevertinib. It's being tested on people with a specific type of lung cancer. The results from the second phase of trials show that 60% of patients responded well to the treatment. This includes 25 partial responses and one

reading time less than a minute
Dec 03 2025FINANCE

Super Micro Computer: Is the Tech Giant Losing Its Edge?

Super Micro Computer, Inc. (SMCI), a major player in the tech world, is facing some tough times. Based in San Jose, California, SMCI is known for making high-performance servers and storage solutions. With a market cap of $19. 9 billion, it's definitely a big fish in the tech pond. But lately, its s

reading time less than a minute
Dec 03 2025CRYPTO

Crypto Stocks: Why American Bitcoin Might Not Be a Smart Buy

American Bitcoin (ABTC) shares took a big hit, dropping nearly 49% recently. This isn't just a small dip. It's part of a much bigger problem in the crypto world. Bitcoin itself has fallen about 30% from its peak earlier this year. This drop has caused a lot of trouble, with over $19 billion lost and

reading time less than a minute
Dec 03 2025CRYPTO

Bitcoin's Big Bounce: What's Driving the Crypto Surge?

Bitcoin's value jumped by around 6% in just one day. This sudden rise caught the attention of many investors and traders. It also led to a lot of activity in crypto-related exchange-traded funds (ETFs). Among them, BlackRock’s iShares Bitcoin Trust (IBIT) stood out. It saw a huge trading volume of a

reading time less than a minute
Dec 03 2025BUSINESS

What's the Deal with Ubisoft's Stock?

Ubisoft's stock is in the spotlight again. Barclays' Nick Dempsey has kept his Hold rating on the company, setting a price target of €6. 40. This news comes after a recent report from Dempsey, who is known for his decent track record in the Communication Services sector. Dempsey isn't the only one

reading time less than a minute